Phase I safety and pharmacokinetics of BAY 43-9006 administered for 21 days on/7 days off in patients with advanced, refractory solid tumours (Q36615874)
scientific article published on May 2005
Language:
(P31) (Q13442814)
(P304) 1855-1861
(P407) (Q1860)
(P433) 10
(P478) 92
(P577) Sunday, May 1, 2005
(P921) (Q323936)
(P1433) (Q326309)
(P1476) "Phase I safety and pharmacokinetics of BAY 43-9006 administered for 21 days on/7 days off in patients with advanced, refractory solid tumours" (language: en)
(P2093) Awada A
Hendlisz A
Gil T
Bartholomeus S
Mano M
de Valeriola D
Strumberg D
Brendel E
Haase CG
Schwartz B
Piccart M
(P2860) (Q29617585)
(Q24676378)
(Q27860760)
(Q34376383)
(Q35078119)
(Q28362229)
(Q28203384)
(Q33887368)
(Q27860904)
(Q39446559)
(Q28297412)
(Q24314857)
(Q36568076)
(Q24321753)
(Q42823282)
(Q57281056)
(Q74421259)
other details
description scientific article published on May 2005

External Links